Literature DB >> 17634268

A carbohydrate-restricted diet alters gut peptides and adiposity signals in men and women with metabolic syndrome.

Matthew R Hayes1, Carla K Miller, Jan S Ulbrecht, Joanna L Mauger, Lynn Parker-Klees, Melissa Davis Gutschall, Diane C Mitchell, Helen Smiciklas-Wright, Mihai Covasa.   

Abstract

Carbohydrate-restricted diets have been shown to enhance satiation- and other homeostatic-signaling pathways controlling food intake and energy balance, which may serve to reduce the incidence of obesity and metabolic syndrome. This study was designed as a correlational, observational investigation of the effects of a carbohydrate-restricted diet on weight loss and body fat reduction and associated changes in circulating leptin, insulin, ghrelin, and cholecystokinin (CCK) concentrations in overweight/obese patients (4 men and 16 women) with metabolic syndrome. Subjects received clinical instruction on the initiation and maintenance of the commercial South Beach Diet, consisting of 2 phases: Phase I (initial 2 wk of the study) and Phase II (remaining 10 wk). Participants showed a decrease (P < 0.05) in body weight (93.5 +/- 3.6 kg vs. 88.3 +/- 3.4 kg), BMI (33.9 +/- 1.3 kg/m(2) vs. 32.0 +/- 1.3 kg/m(2)), waist circumference (112.8 +/- 2.8 cm vs. 107.7 +/- 3.0 cm), and total percent body fat (40.2 +/- 1.5% vs. 39.2 +/- 1.5%) by study completion. Plasma fasting insulin and leptin concentrations decreased significantly from baseline concentrations (139.1 +/- 12.2 pmol/L and 44.1 +/- 4.5 microg/L, respectively) by the end of Phase I (98.6 +/- 2.6 pmol/L and 33.3 +/- 4.1 microg/L, respectively). Plasma fasting ghrelin concentrations significantly increased from baseline (836.7 +/- 66.7 ng/L) by Phase II (939.9 +/- 56.8 ng/L). The postprandial increase in plasma CCK concentrations (difference in plasma CCK concentrations from fasting to postprandial) after Phase I (2.4 +/- 0.3 pmol/L) and Phase II (2.5 +/- 0.4 pmol/L) was significantly greater than the postprandial increase at baseline (1.1 +/- 0.5 pmol/L). Collectively, these results suggest that in patients with metabolic syndrome, improved adiposity signaling and increased postprandial CCK concentrations may act together as a possible compensatory control mechanism to maintain low intakes and facilitate weight loss, despite an increase in fasting ghrelin concentrations and subjective measures of hunger.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634268     DOI: 10.1093/jn/137.8.1944

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  8 in total

Review 1.  Biology's response to dieting: the impetus for weight regain.

Authors:  Paul S Maclean; Audrey Bergouignan; Marc-Andre Cornier; Matthew R Jackman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-06-15       Impact factor: 3.619

Review 2.  Adaptations of leptin, ghrelin or insulin during weight loss as predictors of weight regain: a review of current literature.

Authors:  K Strohacker; J M McCaffery; P S MacLean; R R Wing
Journal:  Int J Obes (Lond)       Date:  2013-06-26       Impact factor: 5.095

3.  A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain.

Authors:  François R Jornayvaz; Michael J Jurczak; Hui-Young Lee; Andreas L Birkenfeld; David W Frederick; Dongyang Zhang; Xian-Man Zhang; Varman T Samuel; Gerald I Shulman
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-08-31       Impact factor: 4.310

4.  [Acne vulgaris. Role of diet].

Authors:  B Melnik
Journal:  Hautarzt       Date:  2010-02       Impact factor: 0.751

5.  Prior weight loss exacerbates the biological drive to gain weight after the loss of ovarian function.

Authors:  Vanessa D Sherk; Matthew R Jackman; Erin D Giles; Janine A Higgins; Rebecca M Foright; David M Presby; Ginger C Johnson; Julie A Houck; Jordan L Houser; Robera Oljira; Paul S MacLean
Journal:  Physiol Rep       Date:  2017-05

6.  The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: a randomized trial in young overweight women.

Authors:  M N Harvie; M Pegington; M P Mattson; J Frystyk; B Dillon; G Evans; J Cuzick; S A Jebb; B Martin; R G Cutler; T G Son; S Maudsley; O D Carlson; J M Egan; A Flyvbjerg; A Howell
Journal:  Int J Obes (Lond)       Date:  2010-10-05       Impact factor: 5.095

7.  Biomarker Profile Does Not Predict Weight Loss Success in Successful and Unsuccessful Diet-Reduced Obese Individuals: a Prospective Study.

Authors:  Sarit Polsky; Lorraine Garratt Ogden; Paul Scown Maclean; Erin Danielle Giles; Carrie Brill; Holly Roxanna Wyatt
Journal:  ISRN Obes       Date:  2013-01-01

Review 8.  Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.

Authors:  Carmela Giordano; Maddalena Marchiò; Elena Timofeeva; Giuseppe Biagini
Journal:  Front Neurol       Date:  2014-04-29       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.